期刊
ANNALS OF ONCOLOGY
卷 16, 期 4, 页码 625-633出版社
OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdi119
关键词
autologous stem cell transplantation; first relapse; Hodgkin's lymphoma
类别
Purpose: To analyse outcome and prognostic factors for overall survival (OS) and time to treatment failure (TTF) in 357 patients with Hodgkin's lymphoma (HL) undergoing an autologous stem cell transplantation (ASCT) after a first relapse and reported to the The Grupo EspaNol de Linfomas/ Trasplante AutOlogo de MEdula Osea (GEL/TAMO) Cooperative Group. Methods: Two hundred and twenty mates and 137 females with a median age of 29 years were autografted in second remission (n = 18 1), first sensitive relapse (n = 148) and first resistant relapse (n = 28). Results: Five-year actuarial TTF and OS were of 49% 3% and 57% 3%. Advanced stage at diagnosis, complementary radiotherapy before ASCT, a short first complete response (CR) and detectable disease at ASCT adversely influenced TTF. Year of transplant <= 1995, bulky disease at diagnosis, a short first CR, detectable disease at ASCT and >= 1 extranodal areas involved at ASCT were adverse factors for OS. Conclusions: ASCT constitutes a therapeutic option for HL patients after a first relapse. Promising results are observed in patients with low tumour burden at diagnosis, autografted after a long CR and without detectable disease at ASCT. Innovative approaches should be pursued for patients with risk factors at relapse.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据